IDH2 and heart disorder: Notably, IDH1 and IDH2 mutations also occur as CHIP mutations [28] and mechanistically lead to conversion of αKG to R-2HG, which is a proven oncometabolite and a potent inhibitor of TET2 [4, 29], suggesting a common pathway of CHIP induced cardiac disease.